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“If you would understand
anything, observe its
beginning and its
development.”
Aristotle

The purpose of Advance
is to highlight research at
the UT Graduate School of
Medicine. While we look
forward to a bright future,
there are important insights
if we harken back to the
glorious days of early research at our institution. Dr.
Alan Solomon, Dr. Wahid Hanna and Dr. Carmen
Lozzio kindly shared with me some of the signature
achievements of the researchers at the Graduate School
of Medicine from the mid-1960s to the mid-1990s.
During this period, the Birth Defects Center was
established and several novel chromosomal abnormalities
were described. Our clinicians were among researchers
at several centers who conducted the first clinical trials
with L-DOPA for treatment of Parkinson’s disease.
The favorable response in one of the subjects who
participated in the study was instrumental in later
funding and developing the Cole Neuroscience Center.
Other notable contributions include
•Development of the K562 cell line from a patient with
chronic myeloid leukemia that continues to be used
to this day by researchers all over the world to study
hematopoietic development;
•Discovery of thrombopoietin;
•Landmark studies on functional properties of
erythropoietin, including experiments with NASA to
elucidate the cause of anemia during space flight;
•Establishment of several clonal plasma cell lines that
continue to provide important insights into the
pathogenesis of multiple myeloma; and
•Development of a monoclonal antibody (11-1F4) that
specifically binds to amyloid fibrils and is capable
of lysing amyloid deposits. The National Cancer
Institute has developed a chimeric derivative of this
antibody for Phase I clinical trials in humans.
Only a few of the major scientific contributions are
mentioned. The list of achievements is long and truly
impressive. Scientists currently working at the Graduate
School of Medicine celebrate the efforts of our senior
colleagues and are proud of their many achievements
and valuable contributions to medical science. The
cadre of researchers at the Graduate School of Medicine
build on what has already been accomplished with the
goal of providing novel treatments for treating human
illnesses and raising the research enterprise to even
greater heights in the future.
The articles in this issue of Advance shine the
spotlight on our talented researchers and their current
accomplishments. These professionals have the ideal
platform to build on our past successes!
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featured researcher

»»»»»»

Eric Carlson: A Life
Career and Success
educating his patients, about
learning all he can about
the diseases that impact his
patients.
It all becomes clear.
Yes, he’s inspired by family
and faith, and he is a lifelong
learner. But to what end? Eric
Carlson, D.M.D., M.D., is
mostly driven by his desire
to succeed on behalf of his
patients. He is the chair of
the Department of Oral and
Maxillofacial Surgery at the
Graduate School of Medicine
and a cancer surgeon. He is a
teacher of residents and fellows,
and he is a clinical researcher.
His educational curriculum,
the research he conducts and
the plans he makes translate
immediately to his patients.

A Perfect Storm
Carlson grew up in
Massachusetts and initially chose
to study dentistry.
“I knew during dental school that I’d broaden
my career,” he says. “I have a strong sense of
curiosity, and I’m motivated by a challenge. The
inquisitive mind is the stimulated mind.” He
then graduated medical school and obtained
residency training in oral and maxillofacial surgery
and general surgery followed by a fellowship in
oral/head and neck surgery.  
A challenge is what he faced when he joined
the Graduate School of Medicine in 2002.  He
characterizes his choice to come to Knoxville with
a weather analogy:
“My educational vision matched that of
Jim Neutens [Dean of the Graduate School of
Medicine], and my clinical vision matched John

Eric Carlson leans on his family for inspiration and balance in life.

After you speak with Eric Carlson for just a
few minutes, you will ask yourself, “What drives
this man?” His energy level is astounding, so is
he fueled by strong coffee? His strategic planning
is grounded yet visionary; has his love of college
football or background in competitive tennis
developed his strategic ability? The walls of his
office proclaim his academic pursuits, so does
intellectual curiosity drive him? His desk is covered
by photos of family; is it they who define him?
Yes.
All of these factors (minus the coffee; his energy
is all his own) influence him.  But then you hear
him speak again and again about his patients,
about improving the health of his patients, about
2

Defined by Family,
for His Patients
Bell’s [physician and director of the University of
Tennessee Medical Center Cancer Institute]. It
was a perfect storm.”
As chair, he has developed the Oral and
Maxillofacial Surgery department and residency
and fellowship programs into nationally
renowned programs.  For the past three years,
in fact, his residency program has received the
highest number of applications of any program
in the country. Part of his strategic plan for the
department is to expand the residency program
from a four-year to a six-year program that will
also permit his residents to earn the doctor of
medicine degree.
“Education is my life,” Carlson says simply.
And he’s not just talking about educating young
doctors. He spends a great deal of time educating
his patients, as well. He believes an educated
patient is far more prepared than merely an
informed patient and can make educated decisions
about his or her treatment.

Eric Carlson (center) with his father, Reinhold A. Carlson;
daughters, Kristen and Katie; and wife, Susan

his free time almost exclusively with the people in
the photographs on his desk:  his two daughters,
beautiful wife and father, who is his role model.
“My father taught me that anything worth
doing is worth doing well,” Carlson says.
He admits that he has probably spent more
time at work than with his beloved family,
but he has tried to create balance in his life by
making time for them along the way. During his
daughters’ childhood, for example, he sometimes
brought them to work with him, and occasionally
they could observe surgeries. No doubt due to
this influence as well as that of his wife, a nurse
who, he says, has faithfully supported him for 24
years, one of his daughters has chosen to study
veterinary medicine, and the other, who just
graduated from high school, believes she will study
nursing. Will they have the same compassion
for their patients that has been modeled by their
father?
“I love my job,” this father, surgeon, teacher
and researcher says. “I want to make a difference
in my patients’ lives. I will use the tremendous
resources at the [University of Tennessee] Medical
Center; I will continue to learn; and I will do
research on behalf of my patients. When their
outcomes are better, my job is more fulfilling,”
he says.

Inspiration and Intellectual
Curiosity
Like education, translational research satisfies
his intellectual curiosity, as well. His strategic
plans for the department include performance
of nationally recognized clinical and basic
science research, and currently he is investigating
squamous cell carcinoma of the oral cavity
associated with human papillomavirus. He is
researching why at the molecular level, it can kill
one patient but spare another with cure realized.
“I want to know why this happens,” Carlson
says. “If we can characterize cancer at the
molecular level, we can offer personalized
approaches to cancer treatment and possibly
realize better outcomes for our patients.”
He loves a challenge, and he is driven by the
desire to improve the health of his patients. As
a result, he works many long hours but still calls
his job “fun.” When he’s not at work, he spends
3

Just Breath
Researching the Mind-Body Connection

Ragi Doggweiler is working to help terminally ill patients and their families and caregivers connect
with conventional and integrative medicine resources to improve their quality of life.

Our brains register pain in at least eight ways.
To Ragi Doggweiler, M.D., they represent many
different opportunities to help chronically and
terminally ill patients improve their quality
of life.
Personal life experiences brought Doggweiler
to embrace a new research study she now
is leading, and the study, itself, has deeply
emotional roots. Brothers, John and Ward
Flynn, grew up in Florida as independent,
sometimes quarrelsome brothers. After decades
apart pursuing their own careers in healthcare

education and administration, Ward was
diagnosed with terminal colon cancer, and
the brothers reunited. Using their experience
in healthcare, they set to work together, and
with Ward as the visionary and John as the
implementer, their work reached John Bell,
M.D., Professor, Department of Surgery, Surgical
Oncology, and Director of the University of
Tennessee Medical Center Cancer Institute.
“One day, John [Bell] sent me an e-mail he
had received from John Flynn,” Doggweiler says.  
“He thought I might be interested in it.”
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he

Doggweiler, an associate
professor at the UT Graduate
School of Medicine and a neurourologist at UT Medical Center, is searching
for ways to improve the quality of life for her
patients who suffer from chronic pelvic pain.
She believes that combining holistic approaches
to patient care with standard medical protocols
could make a difference. To that end, over the
past 10 years, she earned certifications in several
areas of integrative medicine, and last
year, she started a Mind-Body Skills
Group. The field of integrative
medicine recognizes the connection
of body and mind to achieve optimal
care for the patient.
So Doggweiler was, indeed, interested
in the e-mail John Bell had received from
John Flynn.  Seems the Flynn brothers
had started the Institute for the Quality
of Life, or i-QoL, to study how patients
and caregivers manage terminal diseases
and how quality of life can be preserved
and improved. It is an instructional program
including a “calculator” that tracks a patient’s
quality of life in real time.
“The scientific, evidence-based approach to
healthcare naturally focuses almost exclusively
on the health of the body,” says Ward Flynn.  
“My brother and I believe i-QoL is the first
rational integration of conventional healthcare
and complementary care. [Health of the] body,
mind, heart, spirit and setting is critical for
optimal healing.”

Ward Flynn was diagnosed with terminal colon cancer
four years ago. He and his brother, John, have developed
instructional materials to help measure and improve quality of
life for terminally ill patients. The materials now are being used
at the UT Medical Center Cancer Institute to study how the
program might affect patients’ quality of life.

As part of a collaboration with the Cancer
Institute, the calculator will be used to monitor
patients during their treatment courses and will
help to choose alternative approaches that will
be available in the Cancer Institute, including
mindfulness training, acupuncture, yoga and
exercise, food studies and more.
“To get healing, we have to approach care
from many points of view,” Doggweiler says.
“Self-care skills and a supportive environment
can assist an individual to achieve a higher level
of physical, emotional and spiritual wellness
while navigating the experience of disease. With
this approach, physicians will see better results,
and the patient will experience a higher quality
of life. Mind-body medicine, grounded in a
respectful, therapeutic partnership, should be a
central element in the care of every person.”

Why this matters:

Western medicine is beginning to recognize a
connection between the mind and body and how
to use it for the best care possible for patients.
Research to better understand this connection can
lead to improved quality of life for people who are
chronically or terminally ill.
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Alzheimer’s D
Advances in Assessing and Diagnosing

In the Cole Neuroscience Center, John Dougherty is using a new self-test
and a radioimaging agent to assess severity of Alzheimer’s disease.

Medical researchers believe Alzheimer’s disease
is caused or worsened by amyloid deposits in the
brain that contribute to memory loss. Amyloid
is a term that describes an abnormal state
whereby many different types of proteins and
sugar molecules can misfold and form hair-like
fibrils that deposit in vital body organs causing
devastation and eventual death.
Seeing amyloid in the brain is imperative to
diagnosing and staging Alzheimer’s disease, and
for those who suffer from Alzheimer’s or other
forms of amyloid-related dementia, diagnosing
the severity of the condition aids in treatment
decisions and patients’ quality of life.
John Dougherty, M.D., is part of a multidisciplinary and multi-institutional team who are
investigating ways to see amyloid and measure the
severity of cognitive impairment.
“Up to 60 percent of patients with early

indicators of Alzheimer’s disease go undiagnosed
in the primary care setting,” says Dougherty. “We
are making progress to improve that number.”
Dougherty is the director of the Cole
Neuroscience Center at the University of
Tennessee Medical Center (Memory Disorder
Program), and an associate professor of Medicine
in Neurology at the Graduate School of Medicine.
He and others are combining imaging technology
with new assessment tools to determine a reliable
way to diagnose and stage cognitive diseases.
In their research, the team is evaluating a
novel brain amyloid radioimaging agent AVID45 (Amyvid™ Avid Radiopharmaceutical) in
patients who have been diagnosed with early
Alzheimer’s disease or mild cognitive impairment.
The researchers also are using an interactive
computerized self-test developed by Dougherty
and his colleagues at the University of Tennessee,
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Disease:
Knoxville.  The aim of the study is to
determine if the extent of brain amyloid
seen by radioimaging correlates with
test results.
The online test, called alzselftest™, is
an affordable, readily accessible screening
device that can be self administered or
administered by physicians, caregivers or
family members. It evaluates orientation,
visual-spatial abilities, verbal fluency,
memory, attention and executive
processing.
The test also is used in conjunction
with a driving simulator at UT Knoxville
that predicts impaired driving ability in
patients with Alzheimer’s disease.
“We want to promote early diagnosis
of Alzheimer’s disease, so the many people
who are undiagnosed can be diagnosed
and receive treatment early, when it is
most effective,” Dougherty says.  Research
has indicated that alzselftest™ is 95%
accurate in diagnosing Alzheimer’s disease
and 97% accurate in detecting mild
cognitive impairment.
These and other efforts are part of a
comprehensive Alzheimer’s Disease Diagnosis and
Treatment Center soon to be operational that will
combine the resources of the UT Graduate School
of Medicine and University of Tennessee Medical
Center. The new program would provide not
only diagnostic and treatment services for patients
and support services for their caregivers, but it
also would involve the faculty and students at UT
Knoxville’s colleges of Nursing; Social Work; and
Education, Health and Human Sciences.

PET-CT scan of the brain of a patient with Alzheimer’s
disease illustrating amyloid deposition

As part of the Center’s mission, Jon Wall, Ph.D.,
a professor and director of Preclinical and
Diagnostic Molecular Imaging Laboratory, and
his associates are commercializing a new peptide,
p5, that will be used as an imaging agent for
Alzheimer’s disease and other amyloid-associated
illnesses.
For information about the alzselftest™, visit
www.alzselftest.com.

Why this matters:

These important strides in the understanding of
Alzheimer’s and other amyloid diseases enable us
to diagnose more accurately and bring us closer to
prevention and cures of these devastating diseases.
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Clinical Trials:
Maternal Fetal Medicine
Clinical trials are medical research that helps
bring new devices, vaccines or drugs more
quickly to patients. They are monitored by the
Institutional Review Board (IRB), a group of
medical professionals and community
representatives who ensure stringent
adherence to federal regulations and
protection for trial volunteers.
The academic medical center
environment at the UT Graduate
School of Medicine and University
of Tennessee Medical Center
enables and encourages physicians
to conduct clinical trials to
seek improved care for their
patients. The professionals in
the Maternal Fetal Medicine
department at UT Medical
Center have several trials
under way.
Craig Towers, M.D.,
is the principal
investigator in a
trial studying
testing of fetal
lung maturity.
The objective of
the trial is to ascertain
the accuracy of the lamellar body count in amniotic
fluid containing blood. Little research exists on
the effect that maternal blood has on the lamellar
body count, which is a well-established test for fetal
lung maturity. This clinical trial will examine the
effect of maternal blood on the test in amniotic
fluid in women who are not on heparin therapy to

determine if the presence of blood skews the results.
This test currently is enrolling.
The Maternal Fetal Medicine department,
headed by Bobby Howard, M.D., also is studying
a drug to stop labor. Howard is leading
the study that is comparing intravenous
and oral administrations of an oxytocin
receptor antagonist being developed
for the treatment of pre-term labor
in healthy, pregnant women. Preterm birth is the largest single cause
of infant morbidity and mortality.
The first phase of this trial has been
completed, and the next phase
will offer enrollment soon.
A study comparing two
treatments to induce labor
has recently concluded.
More than 20% of pregnant
women in the U.S. require
medical intervention to
induce labor, and the
rate is continuing to
rise. Mark Hennessy,
M.D., and his team
compared two vaginal
inserts to find a safer and more
effective means to induce active labor.  For more
information about the Maternal Fetal Medicine
studies, contact Stephanie Porter, 865-305-8888.

A comprehensive list of clinical trials being
conducted nationwide can be found at www.
clinicaltrials.gov.

Why this matters:

Clinical trials provide answers to patients and
physicians and help develop new treatments for a
variety of medical conditions.
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Slowing Prostate Cancer

In Brief

Wesley White and Frederick Klein are working with UT Knoxville researchers to
study the effects of an herbal supplement to slow prostate cancer.

Researchers at the UT Graduate School of
Medicine and University of Tennessee Knoxville
are studying the effects of Zyflamend™ to
slow or halt the progression of prostate cancer.
Zyflamend™ is a commercially available herbal
supplement that has been shown to slow or halt
the progression of certain prostate cancer cells.
UT Graduate School of Medicine physicians,
Frederick Klein, M.D., chief of the Division of
Urological Surgery, and Wesley White, M.D.,
director of Laparoscopic and Robotic Urologic
Surgery, and other members of the Department

of Urology, along with UT Knoxville researchers,
Jay Whelan, Ph.D., head of the Department
of Nutrition, and Paul Terry, Ph.D., associate
professor of Public Health, are collaborating on
the study.
Other than skin cancer, prostate cancer is the
most commonly diagnosed malignancy among
men. The American Cancer Society estimates
more than 200,000 men in the U.S. will be
diagnosed with prostate cancer in 2012.  One in
six American men will develop it, and more than
30,000 will die of prostate cancer this year.

Why this matters:

Given the aging population and prevalence of
prostate cancer, a positive finding in this study
would potentially allow patients of advanced age
or those with significant additional diseases a
non-invasive means of delaying prostate cancer
progression.
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In Brief
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A Better Look Inside
A conventional
Branca and his
bronchoscopy is
team compared
performed by inserting
30 conventional
a bronchoscope into
bronchoscopies
the airways and taking
with 30 conducted
a look around. It
noninvasively with
provides doctors with a
PET-enhanced CT
visual tour of the throat,
imaging. The PETlarynx, trachea and
CT bronchoscopies
lower airways and allows
used specially designed
therapeutic maneuvers,
software that digitally
such as taking specimens
reconstructed the airway
for biopsy. Limitations
structure, showing not
of this procedure,
only anatomical but also
though, occur from
metabolic images of the
the equipment, itself:  
airway.
It simply cannot see
“It is early in the
everything, particularly
study, but the results
Paul Branca is investigating noninvasive ways to
cancer.
are promising,” Branca
perform bronchoscopies.
In 2009, Paul Branca,
says. “I believe they
M.D., Clinical Assistant
tell us there is a better,
Professor, Department of Medicine, and Chief of
less invasive way to perform bronchoscopies
Critical Care Medicine, embarked on a study to
that could result in more accurate diagnoses for
find a better, noninvasive way to get a look inside
patients.”
to more accurately diagnose his patients’ airway
Next, Branca will compile and analyze the
conditions.
results of the first study and seek to begin a
“We have one of the most sophisticated
clinical trial for a more comprehensive study.
pieces of imaging technology in the world, and
I believed it could be used to improve results of
bronchoscopies,” Branca says, in reference to the
PET-CT scanner at the University of Tennessee
Medical Center.

Why this matters:

According to the American Thoracic Society, more
than 500,000 bronchoscopies are performed
each year in the U.S. to diagnose airway bleeding,
difficulty in breathing, lung cancer and other
problems. This research could lead to more
accurate diagnoses for patients suffering with
airway-related conditions.
10

In Brief

»»»»»»

Paper-and-Pencil Research
Makes Surgery Safer
complications and improve surgical
outcomes for patients.
The Department of Surgery has been
using NSQIP since 2009, and to date, more
than 1,600 surgical procedures have been
analyzed.
“We are able to see analysis of our
procedures, physicians and outcomes,” says
Brian J. Daley, M.D., a professor in the
Department of Surgery. “Improvements
occur because we can quickly identify a
problem and change our practice using
evidence-based medicine and because we
simply are more focused on problems and
continually seek ways to solve them.”
Daley notes improvements have occurred
in the rates of deep vein thrombosis,
superficial wound infections and more.
Using NSQIP not only allows the
department to track its own data, but
the program also provides data from peer
institutions with similar patients. This
allows sharing of best practices, learning
from each other.
The University of Tennessee Medical
Center is part of a collaborative comprised of
ten Tennessee hospitals using NSQIP together.
Collaboration such as this increases the sharing
of best practices, identifies region-specific trends
and reduces costs associated with surgery and
complications. Most recent results from this
collaboration indicate significant improvement
of surgical outcomes through reduction of
rates of acute renal failure, infections and other
complications.

Brian Daley and team members track surgical
outcomes for better patient care.

It’s not all done with test tubes. Sometimes,
research using paper and pencil and keen
observation can help an institution improve
patient care.
This is the case with a quality-improvement
initiative used by the Department of Surgery.
The American College of Surgeon’s National
Surgical Quality Improvement Program
(NSQIP) helps medical institutions track surgical
procedures and results to identify preventable

Why this matters:

A relatively simple research tool can track
problems and help institutions devise
improvements. This means better surgical
outcomes for patients.
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In Brief
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New Technology
for Chronic
Wound Healing

Michael Karlstad and a team from Advanced Plasma Products are investigating a better way to heal chronic wounds.

Chronic wounds affect more people than heart
attacks and strokes combined. Usually, chronic
wounds result from diabetes, lower-extremity
arterial disease, pressure ulcers and traumatic
injuries, and more than 100,000 people die from
complications from these wounds each year.
Chronic wounds are difficult to treat. Often,
they contain complex bacteria, and much of the
time, the patient’s immune system is weakened,
further slowing eradication of infection.
Michael Karlstad, Ph.D., a professor in
the Department of Surgery, is working with
Advanced Plasma Products in Knoxville using
funds from a National Institutes of Health
Small Business Innovation Research Phase I
grant to develop and test a new way to treat

chronic wounds. The new technology creates
a unique antimicrobial gas that is directed
onto a wound, thereby disinfecting it and
stimulating wound healing but causing no
harm to surrounding tissue. This is the only
gaseous treatment for wound healing currently
in development for commercial use.
“Advanced Plasma Products has developed
a new technology using atmospheric plasma
to treat chronic wounds,” Karlstad says.  “We
are providing histological analyses and are
preparing to test the technology in animal
studies. We are excited to be involved in this
research because of the impact this technology
can have for many patients.”

Why this matters:

More than five million people in the U.S. suffer
from chronic wounds, and because of the
increase of the rates of obesity and diabetes, the
incidence of chronic wounds will grow. Current
therapeutics have only limited success. This
treatment could improve success with chronic
wound healing, saving up to $20 billion each year
in U.S. healthcare expenditures and improving
patients’ quality of life.
12

News»

Symposium Highlights Collaborations
A dozen research activities led by scientists from
Oak Ridge National Laboratory, University of
Tennessee Medical Center, UT Graduate School of
Medicine and various departments at the University
of Tennessee Knoxville were featured at a recent
Neuroscience Symposium sponsored by the UT
Graduate School of Medicine.
“The symposium offered an opportunity to
connect with other professionals working in
neuroscience to perhaps create new collaborations
or find inspiration for a new avenue of research,”
says Mitch Goldman, M.D., Assistant Dean for
Research.  
Topics included diagnostics for Alzheimer’s
disease; forewarning of epileptic seizures; diagnosis
of brain injury; risk factors for concussion; study
of neurodegenerative disorders; networks for nerve
regeneration; and more.

Study Using Crisis Checklists Funded

(L to R) Seay, Rawn, Black, Scarbro

K. Renee Black, R.N., and Lauren Scarbro, R.N.,
received the Judith Troyer Caudle Award for their
presentation, “A Retrospective Study of Rate of
Infection among Dressings used in Endovascular
Surgeries with Femoral Access Sites.”  Although
limited, the study showed a correlation between
higher infection rates and the use of gauze after
endovascular interventions.  Further research
will examine other dressings and determine how
smoking affects post-operative infection rates.

A collaborative study between the Center for
Advanced Medical Simulation and Department of
Anesthesiology has received funding from Cardinal
Health Foundation’s E3 Grant Program.  Funded is
an implementation of surgical crisis checklists into
the perioperative setting using electronic health
records to improve patient outcomes. Crises in the
surgical setting can include virtually anything from
cardiac arrest to fires. Crisis checklists help the
care team follow established protocols to preserve
the patient’s health and ensure a positive outcome.
Part of the study will include team training in
the Center for Advanced Medical Simulation,
giving the team simulated events in a high fidelity
operating room environment simulation.

Feline Study Receives Grant

Nursing Presentation Awarded

Watch the next issue of Advance for details about
the new 100,000-square-foot Cancer Institute
opening this summer at University of Tennessee
Medical Center. The new facility houses all
outpatient oncology services under one roof, as well
as education resources and cancer research.

A study presented by nurses from the UT Graduate
School of Medicine and University of Tennessee
Medical Center received top honors at the recent
annual conference of the Society for Vascular
Nursing.  Tammy Seay, R.N., Susan Rawn, R.N.,

A collaborative project investigating drug
delivery using a substance similar to a contact
lens has received funding from the Winn Feline
Foundation.  Chris Stephens, Ph.D., a research
assistant professor in the Department of Surgery
and the Center for Materials Processing at the UT
College of Engineering, along with team members
from the UT College of Veterinary Medicine and
UT Department of Biomedical Engineering are
developing a nanoparticle drug delivery method
using a custom-fabricated contact lens in a feline
model. The study is investigating ways to stop
permanent corneal damage.

New Cancer Institute

Your Chance to Advance
The people at the UT Graduate School of Medicine would be happy to discuss
our research programs and how your support can help advance healthcare.  For
information about philanthropic giving to the UT Graduate School of Medicine
Office of Research, please contact the development office at 865-305-6611 or
development@utmck.edu.
If you would like more information about any of the research programs described in
this issue of Advance, please contact the UT Graduate School of Medicine at 865-3059290 or visit us online: http://gsm.utmck.edu/research/main.cfm.

								Thank you.
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